Drugs Pharma

Global Pharma recalls eye drops after FDA contamination warning

blue light filtering not beneficial for eye health

HQ Team

February 4, 2023: India-based Global Pharma Healthcare voluntarily recalled all lots of its artificial tears lubricant eye drops after the USFDA reported possible contamination.

The Centers for Disease Control and Prevention (CDC) alerted FDA to a probe of possible infections following 55 reports of adverse events, including eye infections, permanent loss of vision, and one death with a bloodstream infection.

Ezricare LLC and Delta Pharma distributed eye drops in the US. The FDA stated that the product was distributed Nationwide in the US over the Internet.

“Use of contaminated artificial tears can result in the risk of eye infections that could result in blindness, according to an FDA statement.

Artificial tears lubricant eye drops are used as a protectant against further irritation or to relieve dryness of the eye for the temporary relief of discomfort due to minor eye irritations or exposure to wind or sun. 

Global Pharma Healthcare is notifying the distributors of this product, Aru Pharma Inc. and Delsam Pharma, requesting that wholesalers, retailers and customers who have the recalled product should stop using it.

The recall is being conducted with the knowledge of the US Food and Drug Administration.

The World Health Organisation had issued a medical alert against four cough syrups manufactured by India’s Maiden Pharmaceuticals after linking it with the death of 70 children in Gambia in October.

Uzbekistan government issued an alert against Marion Biotechafter finding contamination in anti-cold syrups that led to the death of 18 people in January 2023. 

Gambia and Uzbekistan claimed to have found diethylene glycol and ethylene glycol in the syrups. The two impurities are fatal and can attack the nervous system.

Leave a Reply

Your email address will not be published. Required fields are marked *